Programm & Abstracts                 "Innovationen in der Augenheilkunde"

Aktuelle Tagungsinformationen
   News and Updates

Anmeldung zur Tagung
   Registration
Hotelbuchung
   Hotel Registration
Grußwort
   Welcome address
Beteiligte Gesellschaften
   Societies involved
Eröffnung des Kongresses
   Opening Ceremony
Preise
   Awards
Wissenschaftliches Programm
   Scientific program
Posterpräsentationen
   Poster Presentation
Kurse
   Courses
Begleitende Veranstaltungen
   Collateral Events
Rahmenprogramm
   Social program
Jubiläumsparty
   Jubilee Party
DOG Information
   DOG Information
Allgemeine Informationen
   General Information
Autorenindex
   Index of Authors
Ausstellerliste
   Exhibitors
Sponsoren
   Sponsors
Teilnahmegebühren
   Registration fees
Impressum



DOG Homepage

Acute Intensive Insulin Therapy Exacerbates Diabetic Blood-Retinal Barrier Breakdown via HIF-1a and Vascular Endothelial Growth Factor

1Joussen A. M., 2Adamis A., 2Qin W., 1Kirchhof B., 2Poulaki V.,
1Universität zu Köln, Zentrum für Augenheilkunde, Abteilung für Netzhaut- und Glaskörperchirurgie (Köln)
2Harvard Medical School, Massachussets Eye and Ear Infirmary (Boston)

Acute intensive insulin therapy is an independent risk factor for diabetic retinopathy progression. The molecular mechanisms underlying this phenomenon remain unknown.
Methods: Diabetic Retinopathy was investigated in a rat model of STZ induced diabetes. VEGF protein and mRNA levels were investigated after intensive insulin therapy.
Results: Here we show that acute intensive insulin therapy markedly increases VEGF mRNA and protein levels in the retinae of diabetic rats. Retinal nuclear extracts from insulin-treated rats contain higher HIF-1a levels and demonstrate an increased binding to radiolabeled probes corresponding to hypoxia-response elements (HRE) in the VEGF promoter. An antibody against HIF-1a induces a supershift, confirming the presence of HIF-1a-containing HRE complexes. Blood-retinal barrier breakdown is markedly increased with acute intensive insulin therapy and is reversed with a VEGF soluble receptor Flt/Fc chimera construct (VEGF TrapA40), but not with an inactive IL-6 receptor/Fc control (IL-6R Trap).
Conclusions: Taken together, these findings indicate that acute intensive insulin therapy produces a transient worsening of diabetic retinopathy via an HIF-1a -mediated increase in retinal VEGF gene expression. These data are the first to identify a specific mechanism for the transient worsening of diabetic retinopathy that follows the institution of intensive insulin therapy.

Zurück/Back